OSMA Update: Regulatory Initiatives in the U.S. and EU

What initiatives are shaping the orthopedic device regulatory landscape in the United States and European Union? OSMA representatives will discuss FDA's stance on MR labeling & testing and biocompatibility. They'll also offer insight from Notified Bodies on the EU MDR implementation.